Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mycophénolate mofétil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil 200mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil 500mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil 1g/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil 500mg/vial powder for injection 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely mycophenolate mofetil 200 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing mycophenolate mofetil in parenteral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mycophenolate mofetil in oral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil hydrochloride (substance) |
Is a |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mycophenolate mofetil (MMF) embryopathy is a malformative syndrome due to the teratogenic effect of MMF, an effective immunosuppressive agent widely used for the prevention of organ rejection after organ transplantation. |
Causative agent (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 250 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 250 mg oral capsule |
Has precise active ingredient |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil 500 mg oral tablet |
Has precise active ingredient |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil hydrochloride (substance) |
Is modification of (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicament contenant seulement mycophénolate mofétil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mycophenolate mofetil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only mycophenolate mofetil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mycophenolate mofetil 200 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mycophenolate mofetil 200 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for infusion and/or injection vial |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for infusion vial |
Has basis of strength substance (attribute) |
True |
Mycophenolate mofetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |